Abstract
The optimal therapy strategy for locally advanced cervical cancer is uncertain, and whether neoadjuvant chemotherapy followed by radical surgery (NACT+RS) could replace the standard concurrent chemoradiation (CCRT) is controversial. We retrospectively evaluated clinical outcomes and adverse effects of patients treated in two different ways and tried to figure out this question.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
